Drug – bio-affecting and body treating compositions – Involving sex selection or contraception
Patent
1988-06-16
1991-03-05
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Involving sex selection or contraception
424 854, 424 856, 424 857, A61K 3766
Patent
active
049976451
ABSTRACT:
Disclosed is a method of treating tumors capable of being treated with interferon which is comprised of interferon and dipyridamole, or pharmaceutically acceptable salts thereof, in amounts sufficient to enhance the anti-tumor effect of interferon. Further disclosed is a pharmaceutical composition comprised of interferon and dipyridamole.
REFERENCES:
patent: 3031450 (1962-04-01), Fischer et al.
Goldstein et al., Career Research, vol. 46, pp. 4315-4329, 1986.
Grem et al., Chem. Abstr. 103:30 (1985).
Grem et al., Cancer Res. 45:2967-2972 (1985).
European Search Report for the corresponding European patent application.
H. Gastpar, Laryngol Rhinol Otol (Stuttg), 62(12):578-85, Dec. 1983 (abstract).
Slichter, S. J., et al., Blood, 59(6):1252-8 (Jun., 1982), abstract.
Chan et al., Canc. Treat. Reports 69:425 (1985).
Chan et al., Canc. Res. 43:3598 (1985).
Zhen et al., Canc. Res. 43:1616 (1983).
Nelson et al., Canc. Res. 44:2493 (1984).
Weber, Canc. Res. 43:3466 (1983).
Bastida et al., Canc. Res. 45:4048 (1985).
Ambrus et al., Proc. Amer. Assoc. Canc. Res. 23:189 (1982).
Biddle et al., Proc. Soc. Exp. Biol. Med. 177:487 (1982).
Wolf et al., J. Med. 15:15 (1984).
Chervinsky et al., Proc. Amer. Assoc Canc. Res. 24:309 (1983).
Galabov et al., Acta Virol. 26:137 (1982).
Suzuki Nobuo
Takakubo Yoshiaki
Boehringer Ingelheim GmbH
Hazel Blondel
LandOfFree
Methods and pharmaceutical composition for the treatment of tumo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and pharmaceutical composition for the treatment of tumo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and pharmaceutical composition for the treatment of tumo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-495403